BAZEDOXIFENE\ESTROGENS, CONJUGATED: 978 Adverse Event Reports & Safety Profile
Thyroid Balance & Feminine Wellness
Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.
978
Total FAERS Reports
3 (0.3%)
Deaths Reported
68
Hospitalizations
978
As Primary/Secondary Suspect
11
Life-Threatening
7
Disabilities
Active Ingredient: BAZEDOXIFENE ACETATE\ESTROGENS, CONJUGATED ·
First Report: 20021202 · Latest Report: 20250601
What Are the Most Common BAZEDOXIFENE\ESTROGENS, CONJUGATED Side Effects?
#1 Most Reported
Drug ineffective
137 reports (14.0%)
#2 Most Reported
Hot flush
86 reports (8.8%)
#3 Most Reported
Vaginal haemorrhage
49 reports (5.0%)
All BAZEDOXIFENE\ESTROGENS, CONJUGATED Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 137 | 14.0% | 0 | 3 |
| Hot flush | 86 | 8.8% | 0 | 3 |
| Vaginal haemorrhage | 49 | 5.0% | 0 | 0 |
| Muscle spasms | 45 | 4.6% | 0 | 1 |
| Headache | 41 | 4.2% | 0 | 4 |
| Off label use | 37 | 3.8% | 0 | 1 |
| Nausea | 36 | 3.7% | 0 | 1 |
| Weight increased | 33 | 3.4% | 0 | 2 |
| Insomnia | 31 | 3.2% | 0 | 3 |
| Feeling abnormal | 30 | 3.1% | 0 | 1 |
| Abdominal pain upper | 28 | 2.9% | 0 | 1 |
| Therapeutic response unexpected | 27 | 2.8% | 0 | 0 |
| Dizziness | 24 | 2.5% | 0 | 2 |
| Pain | 24 | 2.5% | 0 | 4 |
| Anxiety | 22 | 2.3% | 0 | 1 |
| Irritability | 21 | 2.2% | 0 | 0 |
| Neck pain | 21 | 2.2% | 0 | 2 |
| Arthralgia | 20 | 2.0% | 0 | 2 |
| Drug effect incomplete | 20 | 2.0% | 0 | 0 |
| Haemorrhage | 20 | 2.0% | 0 | 0 |
Who Reports BAZEDOXIFENE\ESTROGENS, CONJUGATED Side Effects? Age & Gender Data
Gender: 99.7% female, 0.3% male. Average age: 56.6 years. Most reports from: US. View detailed demographics →
Is BAZEDOXIFENE\ESTROGENS, CONJUGATED Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 5 | 0 | 4 |
| 2004 | 16 | 0 | 15 |
| 2005 | 13 | 0 | 9 |
| 2006 | 3 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 0 |
| 2014 | 45 | 0 | 2 |
| 2015 | 61 | 0 | 7 |
| 2016 | 26 | 0 | 1 |
| 2017 | 25 | 0 | 1 |
| 2018 | 24 | 0 | 3 |
| 2019 | 19 | 0 | 3 |
| 2020 | 32 | 0 | 2 |
| 2022 | 1 | 0 | 0 |
| 2023 | 3 | 0 | 1 |
| 2024 | 14 | 0 | 1 |
| 2025 | 3 | 0 | 0 |
What Is BAZEDOXIFENE\ESTROGENS, CONJUGATED Used For?
| Indication | Reports |
|---|---|
| Hot flush | 164 |
| Menopausal symptoms | 110 |
| Menopause | 104 |
| Hormone replacement therapy | 51 |
| Osteoporosis | 26 |
| Night sweats | 17 |
| Product used for unknown indication | 11 |
| Menopausal disorder | 10 |
| Osteoporosis prophylaxis | 10 |
| Angiopathy | 8 |
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs Alternatives: Which Is Safer?
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BCG VACCINE
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BEBTELOVIMAB
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BECAPLERMIN
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BECLOMETHASONE
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BECLOMETHASONE DIPROPIONATE
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BECLOMETHASONE DIPROPIONATE\FORMOTEROL
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BECLOMETHASONE\FORMOTEROL
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BEDAQUILINE
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BELANTAMAB MAFODOTIN
BAZEDOXIFENE\ESTROGENS, CONJUGATED vs BELANTAMAB MAFODOTIN-BLMF
Official FDA Label for BAZEDOXIFENE\ESTROGENS, CONJUGATED
Official prescribing information from the FDA-approved drug label.